{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:46:53Z","timestamp":1791704813667,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.tranon.2026.103033","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:39:07Z","timestamp":1789508347000},"page":"103033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Multi-omics and experimental validation identify RAPGEF2 as a protective prognostic biomarker in clear cell renal cell carcinoma"],"prefix":"10.1016","volume":"73","author":[{"given":"Yanfei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3101-5800","authenticated-orcid":false,"given":"Shu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2026.103033_bib0001","article-title":"Renal cell carcinoma, nature reviews","volume":"3","author":"Hsieh","year":"2017","journal-title":"Dis. Primers."},{"key":"10.1016\/j.tranon.2026.103033_bib0002","doi-asserted-by":"crossref","first-page":"79","DOI":"10.14740\/wjon1279","article-title":"Epidemiology of renal cell carcinoma","volume":"11","author":"Padala","year":"2020","journal-title":"World J. Oncol."},{"key":"10.1016\/j.tranon.2026.103033_bib0003","doi-asserted-by":"crossref","unstructured":"R.L. Siegel, K.D. Miller, H.E. Fuchs, et al., Cancer statistics, 2022, CA: a cancer journal for clinicians, 72 (2022) 7\u201333.","DOI":"10.3322\/caac.21708"},{"key":"10.1016\/j.tranon.2026.103033_bib0004","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ejso.2016.01.009","article-title":"Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database","volume":"42","author":"Wolff","year":"2016","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.tranon.2026.103033_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.101966","article-title":"Optimizing treatment of renal cell carcinoma with VEGFR-TKIs: a comparison of clinical pharmacology and drug-drug interactions of anti-angiogenic drugs","volume":"84","author":"Fogli","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.tranon.2026.103033_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217616","article-title":"Clinical development of immuno-oncology therapeutics","volume":"617","author":"Wang","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tranon.2026.103033_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217942","article-title":"OTUD3-mediated stabilization of SLC7A11 drives sunitinib resistance by suppressing ferroptosis in clear cell renal cell carcinoma","volume":"632","author":"Xu","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tranon.2026.103033_bib0008","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.3390\/ijms18102195","article-title":"Renal cell tumors: understanding their molecular pathological epidemiology and the 2016 WHO classification","volume":"18","author":"Inamura","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2026.103033_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1195500","article-title":"Metabolic reprogramming of clear cell renal cell carcinoma","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.tranon.2026.103033_bib0010","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s11547-020-01169-z","article-title":"Noninvasive Fuhrman grading of clear cell renal cell carcinoma using computed tomography radiomic features and machine learning","volume":"125","author":"Nazari","year":"2020","journal-title":"Radiol. Med."},{"key":"10.1016\/j.tranon.2026.103033_bib0011","article-title":"New trend in molecular diagnostics: insights from the tumor microenvironment","volume":"3","author":"Zhang","year":"2025","journal-title":"Interdiscip. Med."},{"key":"10.1016\/j.tranon.2026.103033_bib0012","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbrc.2017.09.062","article-title":"Rapgef2, a guanine nucleotide exchange factor for Rap1 small GTPases, plays a crucial role in adherence junction (AJ) formation in radial glial cells through ERK-mediated upregulation of the AJ-constituent protein expression","volume":"493","author":"Farag","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tranon.2026.103033_bib0013","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/nan.12686","article-title":"RAPGEF2 mediates oligomeric A\u03b2-induced synaptic loss and cognitive dysfunction in the 3xTg-AD mouse model of Alzheimer's disease","volume":"47","author":"Jang","year":"2021","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.tranon.2026.103033_bib0014","article-title":"China national center for bioinformation in 2026","volume":"54","year":"2026","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.tranon.2026.103033_bib0015","doi-asserted-by":"crossref","DOI":"10.71321\/lcflx.00001","article-title":"Integrating machine learning and multi-omics to identify key SUMOylation molecular signature in sarcoma","volume":"1","author":"Cheng","year":"2024","journal-title":"Life Conflux."},{"key":"10.1016\/j.tranon.2026.103033_bib0016","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkac959","article-title":"TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment","volume":"51","author":"Han","year":"2023","journal-title":"Nucl. Acids. Res."},{"key":"10.1016\/j.tranon.2026.103033_bib0017","article-title":"Dimensionality reduction for visualizing single-cell data using UMAP","author":"Becht","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tranon.2026.103033_bib0018","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1158\/0008-5472.CAN-23-2650","article-title":"The web-based portal SpatialTME integrates histological images with single-cell and spatial transcriptomics to explore the tumor microenvironment","volume":"84","author":"Shi","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.tranon.2026.103033_bib0019","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s41467-023-36560-7","article-title":"Reconstruction of the tumor spatial microenvironment along the malignant-boundary-nonmalignant axis","volume":"14","author":"Xun","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tranon.2026.103033_bib0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1755-8794-3-21","article-title":"SEURAT: visual analytics for the integrated analysis of microarray data","volume":"3","author":"Gribov","year":"2010","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.tranon.2026.103033_bib0021","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1093\/bioinformatics\/btz229","article-title":"RTNsurvival: an R\/bioconductor package for regulatory network survival analysis","volume":"35","author":"Groeneveld","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.tranon.2026.103033_bib0022","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res."},{"key":"10.1016\/j.tranon.2026.103033_bib0023","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.43","article-title":"Complex heatmap visualization","volume":"1","author":"Gu","year":"2022","journal-title":"Imeta"},{"key":"10.1016\/j.tranon.2026.103033_bib0024","volume":"2","author":"Wu","year":"2021"},{"key":"10.1016\/j.tranon.2026.103033_bib0025","first-page":"131","article-title":"GseaVis: an R package for enhanced visualization of gene set enrichment analysis in biomedicine","volume":"1","author":"Zhang","year":"2025","journal-title":"Med. Res."},{"key":"10.1016\/j.tranon.2026.103033_bib0026","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.tranon.2026.103033_bib0027","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucl. Acids. Res."},{"key":"10.1016\/j.tranon.2026.103033_bib0028","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s40537-023-00844-y","article-title":"BEST: a web application for comprehensive biomarker exploration on large-scale data in solid tumors","volume":"10","author":"Liu","year":"2023","journal-title":"J. Big. Data"},{"key":"10.1016\/j.tranon.2026.103033_bib0029","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2026.103033_bib0030","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.3390\/ijms21134691","article-title":"Immune checkpoint inhibitors in the treatment of renal cancer: current State and future perspective","volume":"21","author":"Lavacchi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2026.103033_bib0031","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cell.2007.05.018","article-title":"GEFs and GAPs: critical elements in the control of small G proteins","volume":"129","author":"Bos","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.tranon.2026.103033_bib0032","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ceb.2005.02.009","article-title":"Linking rap to cell adhesion","volume":"17","author":"Bos","year":"2005","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.tranon.2026.103033_bib0033","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1515\/jtim-2025-0008","article-title":"Development of a broadly potent neutralizing antibody targeting Nidogen 1 effectively inhibits cancer growth and metastasis in preclinical tumor models","volume":"13","author":"Xue","year":"2025","journal-title":"J. Transl. Intern. Med."},{"key":"10.1016\/j.tranon.2026.103033_bib0034","article-title":"Global research status and hotspots of squamous cell carcinoma endothelial cells in the last 20 years: a bibliometric analysis","volume":"1","author":"Li","year":"2024","journal-title":"J. Life Conflux."},{"key":"10.1016\/j.tranon.2026.103033_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118632","article-title":"Current updates and future perspectives on the management of renal cell carcinoma","volume":"264","author":"Singh","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.tranon.2026.103033_bib0036","doi-asserted-by":"crossref","first-page":"28478","DOI":"10.1074\/jbc.M101737200","article-title":"RA-GEF-1, a guanine nucleotide exchange factor for Rap1, is activated by translocation induced by association with Rap1\u00b7GTP and enhances Rap1-dependent B-Raf activation *","volume":"276","author":"Liao","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tranon.2026.103033_bib0037","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrg3185","article-title":"Insights into the regulation of protein abundance from proteomic and transcriptomic analyses","volume":"13","author":"Vogel","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.tranon.2026.103033_bib0038","series-title":"Proceedings of the National Academy of Sciences","first-page":"285","article-title":"Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair","volume":"111","author":"Yu","year":"2014"},{"key":"10.1016\/j.tranon.2026.103033_bib0039","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrc3459","article-title":"BAP1 and cancer","volume":"13","author":"Carbone","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tranon.2026.103033_bib0040","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ng.2323","article-title":"BAP1 loss defines a new class of renal cell carcinoma","volume":"44","author":"Pe\u00f1a-Llopis","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tranon.2026.103033_bib0041","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1470-2045(12)70584-3","article-title":"Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation","volume":"14","author":"Kapur","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.tranon.2026.103033_bib0042","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrneph.2017.59","article-title":"Metabolic reprogramming in clear cell renal cell carcinoma","volume":"13","author":"Wettersten","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.tranon.2026.103033_bib0043","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1158\/2159-8290.CD-18-1354","article-title":"The metabolic basis of kidney cancer","volume":"9","author":"Linehan","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.tranon.2026.103033_bib0044","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1126\/science.aab2674","article-title":"Sestrin2 is a leucine sensor for the mTORC1 pathway","volume":"351","author":"Wolfson","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.tranon.2026.103033_bib0045","doi-asserted-by":"crossref","unstructured":"R.A. Saxton, D.M. Sabatini, MTOR signaling in growth, metabolism, and disease, Cell, 168 (2017) 960\u2013976.","DOI":"10.1016\/j.cell.2017.02.004"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:30:04Z","timestamp":1791703804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326003694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":45,"alternative-id":["S1936523326003694"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103033","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-omics and experimental validation identify RAPGEF2 as a protective prognostic biomarker in clear cell renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103033"}}